Investor Ideas #Potcasts
573, #Cannabis News and #Stocks on the Move; (CSE: $DELC.C) (OTCQB: $DELCF),
(TSXV: $MUSH.V), (CSE: $CURA.C) (OTCQX: $CURLF), (TSXV: $KHRN.V) (OTCQX: $KHRNF)
Delta, Kelowna, BC, June 8, 2021 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/060821-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/06081DELC-MUSH-CURA-KHRN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few private and public company announcements.
Delic Holdings Inc. (CSE:
DELC) (OTCQB:
DELCF), a leading psychedelic wellness platform has
signed a definitive agreement to acquire Ketamine Infusion Centers LLC. KIC is a
limited liability corporation formed under the laws of Arizona, which owns and
operates two ketamine infusion treatment clinics, one in Phoenix, Arizona and
the other in Bakersfield, California.
Supported
by clinical trials and peer reviewed studies, ketamine infusions have emerged
as a promising treatment option for chronic diseases and pain disorders. The
successful completion of the transaction will bring a physical retail footprint
to the DELIC ecosystem where it can leverage its IP, product development and
audience capture through its various leading media properties.
Transaction
Highlights
● The Transaction establishes DELIC as a
diversified psychedelics organization. KIC has been
growing steadily with revenues in excess
of USD$1.5 million since 2019
● KIC will be one of the largest ketamine
clinics, pending recently announced expansion. KIC will double
its footprint to four (4) physical locations in California and Arizona
● KIC will be strategically positioned to
leverage DELIC platform and brand: DELIC expects to
drive patients to KIC through its media platform and become a national leader
● Established history of providing ketamine
infusion services. The management team at KIC has been in business for 3 years expanding
services throughout the United States
● Management expertise. The
acquisition of KIC will add a team of 6 medical professionals and employees bringing a wealth of
industry experience
and knowledge to DELIC
Matt
Stang, Founder and CEO of DELIC commented, "We publicly listed DELIC with
the intent of buying cash-flowing, scalable companies and that is exactly what
KIC represents. We are focused on making psychedelic wellness truly accessible,
and this is a huge development in the realization of that vision."
Sonny
Diaz, Co-Founder of KIC stated, "We were thrilled to be joining the DELIC
platform as we feel their patient acquisition strategy - using DELIC's media
platform to drive patients - is a game changer for scaling our clinics and
expanding patient access. With a history of profitability and a management team
with decades of experience in the health sector and successful exits of over
two dozen clinics and hospitals, KIC's extensive background in operating
clinics and hospitals will enable DELIC to be the leader in legal psychedelic
treatment clinics.
By
acquiring KIC, DELIC expands from its hub of psychedelic education, media, and
information properties and licensed lab and IP company (CBDV) to the ability to
provide patients with psychedelic therapy. DELIC is uniquely positioned to
bring digital awareness to its various holdings under the DELIC umbrella, and
drive online users to brick and mortar clinics.
Over
the last 3 years, the team at KIC has expanded from Arizona to California,
while overseeing 4,000 treatments delivered to date, and generating over
USD$1.5MM in revenue. KIC will operate under the DELIC umbrella, under the
direction and guidance of Dr. Christopher Ray, Sonny Diaz, Rogelio Monzon, and
Ganesh Acharya.
The Good Shroom Co
Inc. (TSXV:
MUSH), a Quebec based company that manufactures functional
beverages under its two brands: Teonan® and Velada™, has
signed an agreement with Mr. Rob Leichman, President of The
Lyric Group, LLC, a leading business development consultant with a particular
expertise in consumer-packaged goods distribution. TGSC has also initiated a
podcast marketing campaign with AdvertiseCast to continue expanding their
e-commerce presence throughout North America.
Lyric Group, LLC to
Lead US Distribution.
The
Lyric Group, LLC launches emerging and established food and beverage brands
onto retail shelves throughout the US. Mr. Leichman and TGSC have come to an
agreement whereby he will lead TGSC's US distribution starting in key states by
utilizing his varied list of established buyer, distributor and merchandizing
relationships across multiple channels to launch the Teonan products. The
Tri-State area (New York. New Jersey and Connecticut) will be the primary focus
and used along with the pacific northwest and northern California.
The
Lyric Group will manage strategy execution from logistics to product placement on
retail shelves alongside the TGSC operations team. TGSC expects to launch its
products in the fall of 2021.
E-commerce
Expansion: Podcast
Over
100 million Americans have listened to a podcast in the last month and the
projected amount of podcast ad spend by the end of the year is over $1 billion.
Additionally, a survey of 300,000 listeners found that 63% of people bought
something a host had promoted on their show.
In
order to continue expanding its e-commerce presence TGSC has initiated
Advertise Cast, one of the premier US podcast advertising networks to manage
its podcast marketing. Advertise Cast and TGSC have identified strategic
podcasters based on the quantity of listeners versus their demographics and
will be marketing its products through podcaster reviews and targeted ads in
various forms. Through this agreement, the Company will gain exposure to a
targeted portion of Advertise Casts's monthly listener reach of over
40,000,000. *
Curaleaf
Holdings, Inc. (CSE:
CURA) (OTCQX:
CURLF), a leading international provider of consumer
products in cannabis, announced a
first-of-its-kind strategic partnership between its Select brand and legendary
music and culture authority Rolling
Stone. Together, the leading lifestyle brand in cannabis joins the most
prominent voice in music and pop culture to celebrate the symbiotic
relationship between music and cannabis. The long term partnership leverages
Select's resources and experience creating progressive, industry-leading
cannabis products alongside Rolling Stone, whose DNA lives at the intersection
of music's past, present and future.
The new line of co-branded Rolling
Stone by Select products will include two product formats to start, including
Select's first-ever pre-roll, as well as "The Cliq," Select's newest
proprietary pod system. Both formats will feature three strains and flavor
profiles hand-selected by Rolling Stone to celebrate some of the most
well-known and genre-defining artists and sounds in music history. The line
includes a berry-forward "Overdrive" Sativa, complex and full-bodied
"Reverb" Indica, and a fruity and calming "Phaser" Hybrid.
"Part of my job at Curaleaf is
building brands people love. Select is a brand built around the relentless
pursuit of progress, and going to great lengths to create the best possible
experience for our consumer. This is a synergy we are honored to share with
Rolling Stone. They are known for having one of the most authentic and
discerning voices in modern journalism, and, as part of that, they've included
cannabis in their coverage for the past 50 years - something many other
publications are only just starting to do today. We're honored and thrilled
that the Rolling Stone team believes in our vision, our products and our people
to create and deliver the highest-quality cannabis products and experiences in
the industry," said Joe Bayern, CEO of Curaleaf.
"Music and Cannabis go hand in
hand," said Rolling Stone President and Chief Operating Officer Gus
Wenner. Rolling Stone has a legacy of celebrating this connection and a long
history of reporting on the fight to legalize cannabis. "We are thrilled
to have found a perfect partner in Curaleaf who gives us the opportunity to
design a product that elevates the music listening experience and celebrates
the deep connection between the two."
Select's commitment to enriching
communities and creating inclusive, meaningful experiences and Rolling Stone's
world class storytelling and culture-defining content inspired the inception of
a first-of-its-kind retail space opening in Las Vegas in 2022. Additional
details on the space will be released in the near future.
In Nevada, Rolling Stone by Select
products will be distributed through Select's wholesale partners and at
Curaleaf's owned dispensaries, including Acres by Curaleaf and Curaleaf Las
Vegas Boulevard. For more information about Select's portfolio of products or find
a dispensary near you that carries Select products, visit us at www.selectcannabis.com.
Khiron Life
Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF), a vertically integrated medical cannabis leader with
core operations in Latin America and Europe, announced the
receipt of the Company's largest ever shipment of EU-GMP certified medical
cannabis product for distribution and sale into the German market.
Recently,
Khiron's German distribution partner, Nimbus Health GmbH, received
approximately 36kg of Khiron 20/1 medical cannabis product, a THC-dominant
cannabis flower product which has been prescribed to patients in the UK since
July 2020. The new product increases the Company's German medical cannabis
offering, which now includes both THC-dominant and CBD-dominant Cannabis products. As a result of the shipment, the Company
expects to increase its European medical cannabis sales in the second quarter
of 2021.
"As
we launch another new product into Germany and more than triple our shipment
volumes, our European team continues to demonstrate strong execution and
leadership. In line with our Mission of improving patients' lives through
medical cannabis, we continue to expand our offering of EU-GMP
cannabinoid-based medicines. Simultaneously, we are developing additional
products based on our Colombian extracts, whose efficacy and safety are backed
by real-world evidence from over 20,000 prescriptions," comments Alvaro
Torres, CEO and Director.
Khiron's
European product portfolio now includes both THC-dominant and CBD-dominant
cannabis flower products available for sale in Germany and the UK, two of the
largest chronic pain markets in Europe. Over the coming months, the Company
plans to increase patient access by expanding its product offering and medical
education initiatives.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Or www.potcasts.ca
Investors can trade these stocks and
other ideas on our site using our list of top stock trading
apps
including Robinhood , Acorn, Stash and others.
To
hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
Potcasts
is now a certified word mark Trademark on the blockchain through Cognate, Inc.
CM Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and
the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
